XML 78 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Current Assets    
Cash and cash equivalents $ 9,676 $ 7,965
Short-term investments 774 899
Accounts receivable (net of allowance for doubtful accounts of $86 in 2019 and $119 in 2018) 6,778 7,071
Inventories (excludes inventories of $1,480 in 2019 and $1,417 in 2018 classified in Other assets - see Note 7) 5,978 5,440
Other current assets 4,277 4,500
Total current assets 27,483 25,875
Investments 1,469 6,233
Property, Plant and Equipment (at cost)    
Land 343 333
Buildings 11,989 11,486
Machinery, equipment and office furnishings 15,394 14,441
Construction in progress 5,013 3,355
Property, plant and equipment (at cost) 32,739 29,615
Less: accumulated depreciation 17,686 16,324
Property, plant and equipment, net 15,053 13,291
Goodwill 19,425 18,253
Other Intangibles, Net 14,196 13,104
Other Assets 6,771 5,881
Total Assets 84,397 82,637
Current Liabilities    
Loans payable and current portion of long-term debt 3,610 5,308
Trade accounts payable 3,738 3,318
Accrued and other current liabilities 12,549 10,151
Income taxes payable 736 1,971
Dividends payable 1,587 1,458
Total current liabilities 22,220 22,206
Long-Term Debt 22,736 19,806
Deferred Income Taxes 1,470 1,702
Other Noncurrent Liabilities 11,970 12,041
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2019 and 2018 1,788 1,788
Other paid-in capital 39,660 38,808
Retained earnings 46,602 42,579
Accumulated other comprehensive loss (6,193) (5,545)
Stockholders' equity before deduction for treasury stock 81,857 77,630
Less treasury stock, at cost: 1,038,087,496 shares in 2019 and 984,543,979 shares in 2018 55,950 50,929
Total Merck & Co., Inc. stockholders’ equity 25,907 26,701
Noncontrolling Interests 94 181
Total equity 26,001 26,882
Total Liabilities and Equity $ 84,397 $ 82,637